Why not the liver instead of the kidney?

Slides:



Advertisements
Similar presentations
RNA interference in biology and disease by Carol A. Sledz, and Bryan R. G. Williams Blood Volume 106(3): August 1, 2005 ©2005 by American Society.
Advertisements

An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe −/− mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia.
Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis Giuseppe D’Amico Kidney International Volume 54, Issue 2, Pages
by Paul A. Carpenter, Meei-Li Huang, and George B. McDonald
Erythropoietin should be part of congestive heart failure management
Gene therapy: efficient targeting of hematopoietic stem cells
The beauty of TLR agonists for CTCL
GVHD-associated immunodeficiency: soil or seed?
Hydroxyurea makes inflammation “just right”?
Platelets come back in from the cold
TCR-MHC-peptide(s): in vivo veritas
Triple play of H pylori in ITP
Pocket-sized iron regulators: one size fits all?
by Henrik Frederiksen, and Kai Schmidt
Neonatal GATA1 mutant clones under the radar
by Jurgen Seppen, Simon C. Barry, Brandon Harder, and William R. A
The Hyperresponsiveness of Cells Expressing Truncated Erythropoietin Receptors Is Contingent on Insulin-Like Growth Factor-1 in Fetal Calf Serum by Jacqueline.
Next-generation leukemia immunotherapy
Knocking out the PCFT by Donald W. Jacobsen Blood
When monocyte life hangs by a thread
It's all in the timing by Linda J. Bendall Blood
A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.
BTK inhibition in myeloma: targeting the seed and the soil
Transplants for the elderly in myeloma
FNAIT: the fetus pleads guilty!
T regulatory cells turn on T regulatory cells
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
Erythropoietin should be part of congestive heart failure management
An Unusual Cause of Abdominal Pain in Sickle Cell Disease
Advances in Biology, Diagnostics, and Treatment of Hodgkin’s Disease
Red blood cell life span and ‘erythropoietin resistance’
What is a true ALCL? by Wolfram Klapper Blood Volume 124(9):
Deep mining of the RBC proteome
Acute promyelocytic leukemia, microgranular variant
Erythropoietin Receptor Mutations Associated With Familial Erythrocytosis Cause Hypersensitivity to Erythropoietin in the Heterozygous State by Stephanie.
Downregulation of the Proinflammatory Cytokine Response to Endotoxin by Pretreatment With the Nontoxic Lipid A Analog SDZ MRL 953 in Cancer Patients by.
An actuarial GPS for hemophilic longevity
Taking a leaf from the book of oral tolerance
Has the T cell bitten off more than it can chew?
by Sabah Sallah, and Jim Y. Wan
Hepatic Cysts in Autosomal Dominant Polycystic Kidney Disease
by Paul A. Carpenter, Meei-Li Huang, and George B. McDonald
HU for acute treatment of sickle VOC?
ESA and iron therapy in chronic kidney disease: a balance between patient safety and hemoglobin target  Szu-Chun Hung, Der-Cherng Tarng  Kidney International 
Gremlin: vexing VEGF receptor agonist
Hepatic Cysts in Autosomal Dominant Polycystic Kidney Disease
by Xingwei Sui, Sanford B. Krantz, Min You, and Zhizhuang Zhao
A new red cell shape helps the clot
Volume 86, Issue 6, Pages (December 2014)
Functional evidence confirmed by histological localization: overlapping expression of erythropoietin and HIF-2α in interstitial fibroblasts of the renal.
59Fe-distribution in conditional ferritin-H–deleted mice
Volume 62, Issue 2, Pages (August 2002)
Volume 70, Pages S21-S25 (December 2006)
This Month in AJKD American Journal of Kidney Diseases
Lipid redistribution in renal dysfunction
Effect of anemia and renal cytokine production on erythropoietin production during blood-stage malaria  Kai-Hsin Chang, Mary M. Stevenson  Kidney International 
Günter Weiss, Florian Kronenberg  Kidney International 
Francesco Locatelli, Lucia Del Vecchio  Kidney International 
Quiz Page August 2007 American Journal of Kidney Diseases
by Christine L. Kempton, and Amanda B. Payne
Volume 56, Issue 2, Pages (August 1999)
Volume 70, Issue 6, Pages (September 2006)
Taqumpay Esmiraldo Tigcal Sacamay, W. Kline Bolton 
Innate Immunity Stimulates Permeability Barrier Homeostasis
Anti-CD20-IL-21 fusokine: the tail wags the dog
Schematic representation of the mechanisms underlying anemia of CKD
Hematopoiesis (The formation of Blood Cells)‏
Initial treatment of CLL: integrating biology and functional status
Fire behind the fury: IL-18 and MAS
Cold agglutinin disease
Presentation transcript:

Why not the liver instead of the kidney? by Joachim Fandrey Blood Volume 120(9):1760-1761 August 30, 2012 ©2012 by American Society of Hematology

Kidneys in renal insufficiency fail to produce erythropoietin (EPO). Kidneys in renal insufficiency fail to produce erythropoietin (EPO). Intravenous injection of lipid nano particles (LNPs) containing siRNA against EglNs activate hepatic EPO synthesis and stimulate erythropoiesis. Professional illustration by Kenneth X. Probst. Joachim Fandrey Blood 2012;120:1760-1761 ©2012 by American Society of Hematology

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com. Inc. All rights reserved.